Receptor‐mediated effects of Δ 9 ‐tetrahydrocannabinol and cannabidiol on the inflammatory response of alveolar macrophages
Immunology & Cell Biology · 2023
DOI: 10.1111/imcb.12614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, 2023. Verfasst von Matthew W Preteroti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Meakins-Christie Laboratories, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Cannabidiol, Cannabinoids, Cannabis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: CIHR, Canadian Institutes of Health Research, Fonds de Recherche du Québec ‐ Santé.
Abstract (Originalsprache)
Δ 9 ‐Tetrahydrocannabinol (Δ 9 ‐THC) and cannabidiol (CBD) are cannabinoids found in Cannabis sativa . While research supports cannabinoids reduce inflammation, the consensus surrounding receptor(s)‐mediated effects has yet to be established. Here, we investigated the receptor‐mediated properties of Δ 9 ‐THC and CBD on alveolar macrophages, an important pulmonary immune cell in direct contact with cannabinoids inhaled by cannabis smokers. MH‐S cells, a mouse alveolar macrophage cell line, were exposed to Δ 9 ‐THC and CBD, with and without lipopolysaccharide (LPS). Outcomes included RNA‐sequencing and cytokine analysis. Δ 9 ‐THC and CBD alone did not affect the basal transcriptional response of MH‐S cells. In response to LPS, Δ 9 ‐THC and CBD significantly reduced the expression of numerous proinflammatory cytokines including tumor necrosis factor‐alpha, interleukin (IL)‐1β and IL‐6, an effect that was dependent on CB 2 . The anti‐inflammatory effects of CBD but not Δ 9 ‐THC were mediated through a reduction in signaling through nuclear factor‐kappa B and extracellular signal‑regulated protein kinase 1/2. These results suggest that CBD and Δ 9 ‐THC have potent immunomodulatory properties in alveolar macrophages, a cell type important in immune homeostasis in the lungs. Further investigation into the effects of cannabinoids on lung immune cells could lead to the identification of therapies that may ameliorate conditions characterized by inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Meakins-Christie Laboratories, Montreal, QC, Canada.
- Translational Research in Respiratory Diseases Program at the Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
- Department of Pathology, Montreal, QC, Canada.
- Department of Medicine, Montreal, QC, Canada.
- Department of Life Sciences, Queen's University, Kingston, ON, Canada.
- Quantitative Life Sciences, McGill University, Montreal, QC, Canada.
Förderung
- CIHR
- Canadian Institutes of Health Research
- Fonds de Recherche du Québec ‐ Santé
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Preteroti, M. W., Traboulsi, H., Greiss, P., Lapohos, O., Fonseca, G. J., Eidelman, D. H., & Baglole, C. J. (2023). Receptor‐mediated effects of Δ 9 ‐tetrahydrocannabinol and cannabidiol on the inflammatory response of alveolar macrophages. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12614
Vancouver
Preteroti MW, Traboulsi H, Greiss P, Lapohos O, Fonseca GJ, Eidelman DH, et al. Receptor‐mediated effects of Δ 9 ‐tetrahydrocannabinol and cannabidiol on the inflammatory response of alveolar macrophages. Immunology & Cell Biology. 2023. doi:10.1111/imcb.12614
BibTeX
@article{Preteroti2023,
author = {Preteroti, Matthew W and Traboulsi, Hussein and Greiss, Patrick and Lapohos, Orsolya and Fonseca, Gregory J and Eidelman, David H and Baglole, Carolyn J},
title = {Receptor‐mediated effects of Δ 9 ‐tetrahydrocannabinol and cannabidiol on the inflammatory response of alveolar macrophages},
journal = {Immunology & Cell Biology},
year = {2023},
doi = {10.1111/imcb.12614}
}
EUVIMED